Technical Analysis for CNAT - Conatus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 0.83 16.90% 0.12
CNAT closed up 16.9 percent on Thursday, April 18, 2019, on 2.12 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CNAT trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 16.90%
New Downtrend Bearish 16.90%
Calm After Storm Range Contraction 16.90%
Narrow Range Bar Range Contraction 16.90%
New 52 Week Low Weakness 16.90%
Wide Bands Range Expansion 16.90%

Older signals for CNAT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection. The company was founded in 2005 and is headquartered in San Diego, California.
Medicine Biotechnology Medical Specialties Hepatitis Infectious Causes Of Cancer Healthcare Associated Infections Hepatocellular Carcinoma Hepatology Hepatitis C Virus Infection Liver Liver Diseases Organ Transplantation Liver Fibrosis
Is CNAT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.74
52 Week Low 0.68
Average Volume 1,216,036
200-Day Moving Average 3.3465
50-Day Moving Average 1.7872
20-Day Moving Average 1.1465
10-Day Moving Average 1.076
Average True Range 0.1963
ADX 25.6
+DI 21.3891
-DI 36.2951
Chandelier Exit (Long, 3 ATRs ) 2.4911
Chandelier Exit (Short, 3 ATRs ) 1.2689
Upper Bollinger Band 1.5447
Lower Bollinger Band 0.7483
Percent B (%b) 0.1
BandWidth 69.463585
MACD Line -0.2953
MACD Signal Line -0.2599
MACD Histogram -0.0353
Fundamentals Value
Market Cap 24.9 Million
Num Shares 30 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -0.85
Price-to-Sales 7.70
Price-to-Book 4.00
PEG Ratio -0.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.15
Resistance 3 (R3) 1.14 1.03 1.09
Resistance 2 (R2) 1.03 0.95 1.03 1.07
Resistance 1 (R1) 0.93 0.90 0.98 0.94 1.06
Pivot Point 0.82 0.82 0.85 0.82 0.82
Support 1 (S1) 0.72 0.74 0.77 0.73 0.60
Support 2 (S2) 0.61 0.69 0.61 0.59
Support 3 (S3) 0.51 0.61 0.57
Support 4 (S4) 0.52